Pharmacokinetics and tissue distribution of the nonadecapeptide Moli1901 in rats and mice
- 1 January 2003
- journal article
- Published by Taylor & Francis Ltd in Xenobiotica
- Vol. 33 (2), 197-210
- https://doi.org/10.1080/0049825021000022320
Abstract
1. Administration of aerosolized, radiolabelled Moli1901 (duramycin, 2622U90), a 19 amino acid polycyclic peptide, to rats resulted in the deposition of high amounts of radiolabel in the respiratory tract, with deposited radiolabel persisting almost unchanged through 7 days after dosing. Little to no radiolabel was present in the bloodstream of these rats. 2. Rats absorbed little radiolabel after p.o. administration, with nearly all of the dose excreted in the faeces by 2 days after dosing. 3. At 7 days following an intravenous dose, rats excreted 54% of the radiolabel in faeces and 5.4% in the urine, with 44% remaining in the carcass, primarily in the liver (33%). 4. Following an intratracheal instillation dose to rats, radiolabel was eliminated from the pulmonary system with a half-life of 64 days. Excretion was almost exclusively via faeces, with an elimination half-life of 52 days. Plasma and blood concentrations in these animals were uniformly <1 ng eq. ml(-1) at all sampling times. 5. Results in mice given intravenous and oral doses were consistent with those observed in rats. 6. Prolonged retention of Moli1901 in pulmonary tissue supports its use in the treatment of respiratory diseases.Keywords
This publication has 9 references indexed in Scilit:
- Recommendations for Guidelines on Clinical Trials of Mucoactive Drugs in Chronic Bronchitis and Chronic Obstructive Pulmonary DiseaseSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 1994
- Cholinergic and adrenergic stimulation of mucociliary trasport in the rat tracheaRespiration Physiology, 1993
- Overview of pulmonary alveolar macrophage renewal in normal rats and during different pathological processes.Environmental Health Perspectives, 1992
- Mode of action of the lanthionine-containing peptide antibiotics duramycin, duramycin B and C, and cinnamycin as indirect inhibitors of phospholipase A2Biochemical Pharmacology, 1991
- Activation by Extracellular Nucleotides of Chloride Secretion in the Airway Epithelia of Patients with Cystic FibrosisThe New England Journal of Medicine, 1991
- Duramycin enhances chloride secretion in airway epitheliumAmerican Journal of Physiology-Cell Physiology, 1990
- The structure of PA48009: The revised structure of duramycin.The Journal of Antibiotics, 1990
- Interaction of duramycin with artificial and natural membranesBiochemistry, 1985
- Antibiotics Against Plant Disease. III. Duramycin, A New Antibiotic from Streptomyces cinnamomeus forma azacoluta2Journal of the American Chemical Society, 1958